Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $2.0 million.

  • Arcus Biosciences' Depreciation & Amortization (CF) changed 0.0% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.0 million for FY2024, which is 2500.0% up from last year.
  • Latest data reveals that Arcus Biosciences reported Depreciation & Amortization (CF) of $2.0 million as of Q3 2025, which was down 0.0% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Depreciation & Amortization (CF) ranged from a high of $3.0 million in Q4 2023 and a low of $800000.0 during Q1 2021
  • Its 5-year average for Depreciation & Amortization (CF) is $1.8 million, with a median of $2.0 million in 2022.
  • Over the last 5 years, Arcus Biosciences' Depreciation & Amortization (CF) had its largest YoY gain of 20000.0% in 2023, and its largest YoY loss of 5000.0% in 2023.
  • Quarter analysis of 5 years shows Arcus Biosciences' Depreciation & Amortization (CF) stood at $1.4 million in 2021, then decreased by 29.43% to $1.0 million in 2022, then soared by 200.0% to $3.0 million in 2023, then changed by 0.0% to $3.0 million in 2024, then plummeted by 33.33% to $2.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $3.0 million for Q1 2025.